4 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
post-thrombotic syndrome ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #DVT #hematology ... #length #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation